Interferon and biologic signatures in dermatomyositis skin: Specificity and heterogeneity across diseases

Agriculture & Biology

• dermatomyositis 100%
• interferons 61%
• skin (animal) 41%
• interferon-gamma 9%
• scleroderma (skin disease) 8%
• inflammation 7%
• interferon-beta 6%
• atopic dermatitis 5%
• acne 5%
• psoriasis 5%
• autoimmune diseases 5%
• sclerosis 5%
• muscles 5%
• herpes simplex 5%
• gene regulatory networks 4%
• pathogenesis 3%
• complement 3%
• lungs 3%
• genes 2%
• blood 2%
• genome 2%
• infection 2%
• tissues 1%
• cells 1%
• methodology 1%

Medicine & Life Sciences

• Dermatomyositis 66%
• Interferons 49%
• Skin 29%
• Localized Scleroderma 12%
• Interferon Type I 10%
• Interferon-beta 10%
• Systemic Scleroderma 10%
• Interferon-gamma 8%
• Allergic Contact Dermatitis 5%
• Muscles 5%
• Inflammation 5%
• Herpes Simplex 5%
• Complement Activation 5%
• Acne Vulgaris 5%
• Gene Regulatory Networks 4%
• Atopic Dermatitis 4%
• Psoriasis 4%
• Autoimmune Diseases 3%
• Genes 3%
• Up-Regulation 3%
• Genome 3%
• Messenger RNA 2%
• Lung 2%
• Infections 2%
• In Vitro Techniques 1%

Chemical Compounds

• Heterogeneity 49%